The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“Tetramer synthesis and T-cell specificity analysis R-phycoerythrin (PE)- or allophycocyanin (APC)-conjugated HLAA2/peptide complex tetramers were synthesized as described before (Altman et al., 1996) for the antigens tyrosinase369-377 (YMDGTMSQV), gp100280-288 (YLEPGPVTA), gp100209-217 (ITDQVPFSV), MART-126-35 (modifi…”
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575 · cited 1×
“Occasionally, leukoderma is observed after melanoma immunotherapy using tumor cell vaccination or adoptive T-cell transfer therapy, and was found to be associated with prolonged survival (Yee et al., 2000; Dudley et al., 2002; Phan et al., 2003; Luiten et al., 2005).”
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death
Chowdhury, D., & Lieberman, J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090404 · Cited by 700
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Self-citationTrautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.-U., Graeve, T., Noll, M., Bröcker, E.-B., Blaser, K., & Akdis, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9199 · Cited by 495
High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Research works printed but not linked: 4
- Dickinson, 1988, Skin explant culture as a model for cutaneous graft-versus-host disease in humans, Bone Marrow Transplant, 3, 323
- Hann, 1992, Epidermal changes in active vitiligo, J Dermatol, 19, 217, 10.1111/j.1346-8138.1992.tb03211.x · doi:10.1111/j.1346-8138.1992.tb03211.x
- Montes, 2002, Vitiligo, Lancet, 360, 405, 10.1016/S0140-6736(02)09612-5 · DOI
- Vogelsang, 1985, An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants, N Engl J Med, 313, 645, 10.1056/NEJM198509123131101 · doi:10.1056/nejm198509123131101
Cited by
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60763-7 · Cited by 943
Bergqvist, C., & Ezzedine, K. (2020) · Dermatology · doi:10.1159/000506103 · Cited by 799
CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
Cheuk, S., Schlums, H., Gallais Sérézal, I., Martini, E., Chiang, S. C., Marquardt, N., Gibbs, A., Detlofsson, E., Introini, A., Forkel, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.009 · Cited by 678
Vitiligo: Mechanisms of Pathogenesis and Treatment
Frisoli, M. L., Essien, K., & Harris, J. E. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100919-023531 · Cited by 618
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Harris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.463 · Cited by 389
Picardo, M., Dell'Anna, M. L., Ezzedine, K., Hamzavi, I., Harris, J. E., Parsad, D., & Taieb, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.11 · Cited by 326
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin, D., Passeron, T., Pandya, A. G., Grimes, P., Harris, J. E., Desai, S. R., Lebwohl, M., Ruer-Mulard, M., Seneschal, J., Wolkerstorfer, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118828 · Cited by 316
Mechanisms of melanocyte death in vitiligo
Chen, J., Li, S., & Li, C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21754 · Cited by 307
Anatomically distinct fibroblast subsets determine skin autoimmune patterns
Xu, Z., Chen, D., Hu, Y., Jiang, K., Huang, H., Du, Y., Wu, W., Wang, J., Sui, J., Wang, W., et al. (2022) · Nature · doi:10.1038/s41586-021-04221-8 · Cited by 305
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
Richmond, J. M., Strassner, J. P., Zapata, L., Garg, M., Riding, R. L., Refat, M. A., Fan, X., Azzolino, V., Tovar-Garza, A., Tsurushita, N., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7710 · Cited by 301
Vitiligo: A focus on pathogenesis and its therapeutic implications
Bergqvist, C., & Ezzedine, K. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15743 · Cited by 277
Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy
Boniface, K., Seneschal, J., Picardo, M., & Taïeb, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8622-7 · Cited by 272
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Rosmarin, D., Pandya, A. G., Lebwohl, M., Grimes, P., Hamzavi, I., Gottlieb, A. B., Butler, K., Kuo, F., Sun, K., Ji, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30609-7 · Cited by 271
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Boniface, K., Jacquemin, C., Darrigade, A.-S., Dessarthe, B., Martins, C., Boukhedouni, N., Vernisse, C., Grasseau, A., Thiolat, D., Rambert, J., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.038 · Cited by 263
Collier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
T cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi, F., Liu, F., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790125 · Cited by 203
Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity
Wang, Y., Li, S., & Li, C. (2019) · Medical Science Monitor · doi:10.12659/msm.914898 · Cited by 176
Resident Memory T Cells in Autoimmune Skin Diseases
Ryan, G. E., Harris, J. E., & Richmond, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652191 · Cited by 132
Lo, J. A., Kawakubo, M., Juneja, V. R., Su, M. Y., Erlich, T. H., LaFleur, M. W., Kemeny, L. V., Rashid, M., Malehmir, M., Rabi, S. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8636 · Cited by 97
Faraj, S., Kemp, E. H., & Gawkrodger, D. J. (2022) · Clinical and Experimental Immunology · doi:10.1093/cei/uxab002 · Cited by 94
Upadhya, S., Andrade, M. J., Shukla, V., Rao, R., & Satyamoorthy, K. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103841 · Cited by 27
Eleftheriadou, V., Delattre, C., Chetty-Mhlanga, S., Lee, C., Girardat-Rotar, L., Khan, I., Mathew, A., & Thompson, A. R. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae133 · Cited by 21
Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk
Inoue, S. (2026) · The Journal of Dermatology · doi:10.1111/1346-8138.70067 · Cited by 3
Metadata
- Authors
- van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 129
- Issue
- 9
- Pages
- 2220-2232
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2069384112
- Cited by
- 543
- References
- 31
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2283 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.